Expanding the Obesity Pipeline VK3019 Viking is also advancing additional approaches in obesity treatment, including amylin-based therapies designed to expand treatment options and support durable outcomes and improvements in overall metabolic health
These drugs are administered via injectables, with some oral variants in development
BPC-157 operates through several biological pathways: Angiogenesis: It promotes the formation of new blood vessels, which is important for delivering nutrients and oxygen to injured tissues Growth factor modulation: BPC-157 influences key growth factors involved in tissue repair, including VEGF (vascular endothelial growth factor) and EGF (epidermal growth factor) Nitric oxide system: It interacts with the nitric oxide pathway, which regulates blood flow, inflammation, and tissue protection Anti-inflammatory action: BPC-157 helps reduce excessive inflammation, creating a more favorable environment for healing Gut-brain axis: Research suggests BPC-157 may have neuroprotective effects and influence the connection between gut health and brain function What Can BPC-157 Help With
JourneyLites advantage: Because we offer medications, balloons, surgery, and revisions, our team can help patients compare realistic options instead of forcing every patient into the same treatment path
